跳至主要内容
临床试验/NL-OMON36066
NL-OMON36066已完成不适用

Effects of stearidonic acid on serum triacylglycerol concentrations in overweight and obese subjects - Stearidonic acid and lipid metabolism

niversiteit Maastricht0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - aged between 18-70 years
  • - Quetelet-index between 25-35 kg/m2
  • - mean serum triacylglycerol < 3.0 mmol/L

排除标准

  • - unstable body weight (weight gain or loss >2 kg in the past 3 months)
  • - indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus
  • - use of medication or a diet known to affect serum lipid or glucose metabolism
  • - active cardiovascular disease like congestive heart failure or recent (<6 months) event (acute myocardial infarction, cerebro vascular accident)
  • - severe medical conditions that might interfere with the study such as epilepsy, asthma, chronic obstructive pulmonary disease, inflammatory bowel diseases and rheumatoid arthritis
  • - abuse of drugs
  • - more than 21 alcohol consumptions per week for men and 14 consumptions for women
  • - not or difficult to venipuncture as evidenced during the screening visits
  • - use of an investigational product within the previous 30 days
  • - not willing to stop the consumption of vitamin supplements, fish oil capsules or products rich in plant stanol or sterol esters 3 weeks before the start of the study
  • - not willing to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study and during the study

研究者

相似试验